The Lancet HIV in conversation with
Peter Hayward, Editor-in-Chief, and Adrian Gonzalez-Lopez, Senior Editor at The Lancet HIV, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.
A monthly audio companion to the journal, this podcast covers a broad range of topics, from treatments of children with HIV to COVID-19 and chemsex, the experiences of HIV among global Indigenous populations to intimate partner violence and women with HIV, and more.
The Lancet HIV in conversation with
Lise Jamieson and Gesine Mayer-Rath on cabotegravir for PrEP in South Africa
Deputy Editor Philippa Harris talks to Lise Jamieson (Health Economics and Epidemiology Research Office, University of Witswatersrand, South Africa) and Gesine Mayer-Rath (Health Economics and Epidemiology Research Office and the University of Boston, USA) about cost-effectiveness of long-acting cabotegravir for PrEP in South Africa.
Read the full article:
Relative cost-effectiveness of long-acting injectable cabotegravir versus oral pre-exposure prophylaxis in South Africa based on the HPTN 083 and HPTN 084 trials
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv